NovaBridge Biosciences (NBP): Depreciation & Amortization

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Depreciation & Amortization is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

23.90M CNY
Year ended 2023-12-31
+23.5%
3-year compound annual growth
+29.0%
5-year compound annual growth
25.30M CNY2017-12-31: 1.60M CNY2018-12-31: 6.70M CNY2019-12-31: 9.80M CNY2020-12-31: 12.70M CNY2021-12-31: 13.80M CNY2022-12-31: 25.30M CNY2023-12-31: 23.90M CNY23.90M CNY
2017-12-31 Depreciation & Amortization (CNY) 2023-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2023-12-3123.90M CNY-5.5%2024-04-30, From 2023-01-01
2022-12-3125.30M CNY+83.3%2024-04-30, From 2022-01-01
2021-12-3113.80M CNY+8.7%2024-04-30, From 2021-01-01
2020-12-3112.70M CNY+29.6%2023-05-01, From 2020-01-01
2019-12-319.80M CNY+46.3%2022-04-29, From 2019-01-01
2018-12-316.70M CNY+318.8%2021-04-28, From 2018-01-01
2017-12-311.60M CNYn/a2020-04-29, From 2017-01-01